Author: Martin Holloway
Martin Holloway spent the better part of two decades on bank trading floors in the City before he started filing copy. He read Economics at a redbrick university, joined a graduate scheme at one of the UK clearers in the late 1990s, and moved across to fixed income early in his career. The bulk of his time was on macro desks at European banks, running short-end and cross-asset positions through the 2008 crisis and the long grind of the post-crisis rates regime. He stepped off the desk toward the end of the last decade, did a stint consulting on the buy side, and started writing in 2020. He covers the bits of the City he actually knows: rates, FX, UK banks, gilt issuance, and the corporate news that moves them. He has a working theory about why nobody on the sell side saw the 2022 gilt crisis coming, and is happy to share it at moderate length. Martin lives in the South East with his family. He reads the FT in the morning out of habit rather than affection, and treats most market commentary as marketing collateral written by people who have never held risk overnight.
Thruvision (LON: THRU) shares surged 113% to 1.33p after the security technology firm disclosed a…
Onswik FDA approval: Eli Lilly’s once-weekly insulin wins US clearance for type 2 diabetes, but LLY shares slipped on the day.
SpaceX stock valuation faces a sharp test after the rocket and satellite company posted its…
Amazon’s quick-commerce investment in India could reach $3bn by 2030, Reuters reports, as the retailer chases rivals holding most of the market.
Dolby Atmos Meta deal brings spatial audio to AI glasses and a 2027 VR headset, but DLB shares remain 6.86% lower over 20 days.
Greggs shares H1 2026 performance sent the stock up roughly 18% over the past month,…
Barry Diller’s People Incorporated withdrew its bid for MGM Resorts on 23 September 2026, ending a $18bn take-private plan, not a majority-stake offer.
Meta unveiled camera-free smart glasses at Connect 2026, adding a privacy-focused line alongside its camera-equipped Ray-Ban range.
Oracle’s oncology EHR launch brings AI tools to cancer care teams, but shares fell 1.85% on the day of the announcement.
IonQ’s Nvidia quantum deal secures the first on-site processor slot at NVAQC – but installation is set for 2027, and Wednesday’s share rally faded fast.
Amadeus House 27b Floral Street London WC2E 9DP United Kingdom
editor@financial-news.co.uk.
Subscribe to Updates
Get the latest creative news from FooBar about art, design and business.